BioWorld - Monday, February 9, 2026

BioWorld Science

Jan. 17, 2017

View Archived Issues

Dendright extends collaboration with Janssen and adds Arthritis Queensland as a partner

Read More

Eisai, Chugai and Roche sign agreements for flunitrazepam rights in Japan

Read More

Telix and Wilex sign license agreement for Redectane

Read More

Bristol-Myers Squibb patents IRAK-4 inhibitors

Read More

Sumitomo Dainippon Pharma report compounds for treatment of cancer

Read More

European Commission confirms orphan drug designation for TB-403 for medulloblastoma

Read More

Team in Portugal describes antimalarial agents

Read More

AnaMar reports 5-HT2B receptor antagonists

Read More

GlaxoSmithKline patents EZH2 inhibitors for cancer

Read More

Pierre Fabre reports Plk-1 inhibitors

Read More

177Lu-PSMA-617 demonstrates favorable safety and high efficacy in patients with mCRPC

Read More

Results from second pivotal trial of ulipristal acetate for abnormal uterine bleeding

Read More

Bivalent Vaxwave vaccine shows in vivo efficacy in models of cytomegalovirus infection

Read More

Evotec and MaRS Innovation announce launch of Fibrocor Therapeutics

Read More

NRC supports Fedora's development of antimicrobial product candidates

Read More

AstraZeneca updates status of durvalumab trials in first-line NSCLC

Read More

FDA designates NS-065 an orphan drug for the treatment of Duchenne muscular dystrophy

Read More

Horizon Discovery broadens gene-editing capabilities

Read More

Audentes Therapeutics gives update on programs at J.P. Morgan meeting

Read More

Novogene to acquire Pacific Biosciences' Sequel Systems

Read More

CytomX initiates first-in-human study of CX-072 to treat solid tumors and lymphomas

Read More